Showing results (1591-1600 of 1,762) with videos related to

Sort By:
Pageof 177
Haematologica|November 10, 2018
The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14Beatrice Drexler, Jakob R Passweg, Alexandar Tzankov, et al.
Blood|January 6, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germline ERCC6L2 diseaseRoman Schimmer, Nancy Klemm, Jonas Fullin, et al.
Metabolomics : Official Journal of the Metabolomic Society|December 14, 2023
Maternal and newborn metabolomic changes associated with urinary polycyclic aromatic hydrocarbon metabolite concentrations at delivery: an untargeted approachJagadeesh Puvvula, Kathrine E Manz, Joseph M Braun, et al.
Environmental Health Perspectives|May 26, 1998
Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congenersD Jung, P A Berg, L Edler, et al.
ACS Omega|July 29, 2025
Smoldering Treatment of PFAS: Investigation of Mass Balance and Volumetric Scale Up for Field ImplementationBrian G Harrison, David W Major, Laura L Kinsman, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|January 2, 2017
A genome wide association study of fast beta EEG in families of European ancestryJacquelyn L Meyers, Jian Zhang, Niklas Manz, et al.
Cancer Cell|July 14, 2012
Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathwayMonika Julia Wolf, Alexandra Hoos, Judith Bauer, et al.
Nature Communications|March 16, 2026
Candesartan cilexetil disrupts methicillin-resistant Staphylococcus aureus membrane and potentiates gentamicin and polymyxin B activityNagendran Tharmalingam, Robert Wilson Kovacs, Suelen Scarpa de Mello, et al.
JAMA Network Open|January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical TrialBrandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
The Journal of Clinical Investigation|May 27, 2015
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasmsLukas F Mager, Carsten Riether, Christian M Schürch, et al.
Pageof 177